A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge buy on Thursday. Specifically, these funds bought roughly $15 million worth of Ginkgo Bioworks Holdings Inc. (NYSE: DNA), as the prices of these ETFs were down on Thursday.
[in-text-ad]
ARK Genomic Revolution ETF (NYSEARCA: ARKG) bought 698,931 shares, while ARK Innovation ETF (NYSEARCA: ARKK) bought 1,426,097 shares. At Thursday’s closing price, this would have valued the sales at roughly $14.7 million altogether. Even though this is a small fraction of their total holdings, every little bit counts. The Genomic Revolution ETF is down more than 46% and the other is down 38% in the past year.

Check out all the ARK Invest purchases for Thursday as well:

Fund	Ticker	Name	Shares
ARKG	BNR	BURNING ROCK BIOTECH	4,000
ARKG	DNA	GINKGO BIOWORKS	698,931
ARKG	NRIX	NURIX THERAPEUTICS	44,628
ARKG	NTLA	INTELLIA THERAPEUTICS	25,739
ARKG	PSNL	PERSONALIS	59,000
ARKG	QSI	QUANTUM-SI	101,895
ARKG	RXRX	RECURSION PHARMACEUTICALS	28,000
ARKK	SQ	BLOCK	121,727
ARKK	PLTR	PALANTIR TECHNOLOGIES	430,339
ARKK	PATH	UIPATH	184,626
ARKK	NVTA	INVITAE	57,198
ARKK	NTLA	INTELLIA THERAPEUTICS	63,440
ARKK	VCYT	VERACYTE	29,411
ARKK	HOOD	ROBINHOOD MARKETS	487,263
ARKK	ZM	ZOOM VIDEO COMMUNICATIONS	43,550
ARKK	DNA	GINKGO BIOWORKS	1,426,097
ARKK	COIN	COINBASE GLOBAL	35,390
ARKK	CGEN	COMPUGEN	89,164
ARKK	BEAM	BEAM THERAPEUTICS	42,300
ARKK	TWLO	TWILIO	32,533
ARKQ	AVAV	AEROVIRONMENT	20,101
ARKW	ROKU	ROKU	18,074
ARKW	TWOU	2U	13,011
ARKX	MKFG	MARKFORGED	34,624

Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.